These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1414219)

  • 1. Absence of interaction between oxcarbazepine and erythromycin.
    Keränen T; Jolkkonen J; Jensen PK; Menge GP; Andersson P
    Acta Neurol Scand; 1992 Aug; 86(2):120-3. PubMed ID: 1414219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxcarbazepine does not interact with cimetidine in healthy volunteers.
    Keränen T; Jolkkonen J; Klosterskov-Jensen P; Menge GP
    Acta Neurol Scand; 1992 Apr; 85(4):239-42. PubMed ID: 1585795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.
    Ahmad A; Garnett WR
    Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oxcarbazepine and carbamazepine on the central nervous system: computerised analysis of saccadic and smooth-pursuit eye movements.
    Zaccara G; Gangemi PF; Messori A; Parigi A; Massi S; Valenza T; Monza GC
    Acta Neurol Scand; 1992 Jun; 85(6):425-9. PubMed ID: 1642114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.
    McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ
    Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oxcarbazepine in the treatment of epilepsy. A review and update].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Jan 16-31; 42(2):95-113. PubMed ID: 16450324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice.
    Johannessen Landmark C; Svendsen T; Dinarevic J; Kufaas RF; Reimers A; Brodtkorb E; Baftiu A; Burns ML; Johannessen SI
    Ther Drug Monit; 2016 Aug; 38(4):499-505. PubMed ID: 27414974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.
    Elger C; Bialer M; Falcão A; Vaz-da-Silva M; Nunes T; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How is oxcarbazepine different from carbamazpine?].
    Schmidt D; Elger CE
    Nervenarzt; 2004 Feb; 75(2):153-60. PubMed ID: 14770287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine.
    Flesch G; Czendlik C; Renard D; Lloyd P
    Drug Metab Dispos; 2011 Jun; 39(6):1103-10. PubMed ID: 21389120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine.
    Tecoma ES
    Epilepsia; 1999; 40 Suppl 5():S37-46. PubMed ID: 10530693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S; Boppana P; Toguri J; DeSantis A
    Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy.
    Sachdeo RC; Sachdeo SK; Walker SA; Kramer LD; Nayak RK; Doose DR
    Epilepsia; 1996 Aug; 37(8):774-80. PubMed ID: 8764818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
    Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
    Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of oxcarbazepine.
    May TW; Korn-Merker E; Rambeck B
    Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models.
    Fortuna A; Alves G; Soares-da-Silva P; Falcão A
    Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on cyp3a4.
    Andreasen AH; Brøsen K; Damkier P
    Epilepsia; 2007 Mar; 48(3):490-6. PubMed ID: 17346248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratogenicity of carbamazepine-10, 11-epoxide and oxcarbazepine in the SWV mouse.
    Bennett GD; Amore BM; Finnell RH; Wlodarczyk B; Kalhorn TF; Skiles GL; Nelson SD; Slattery JT
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1237-42. PubMed ID: 8968346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics and indications of oxcarbazepine].
    Herranz JL; Argumosa A
    Rev Neurol; 2002 Sep; 35 Suppl 1():S101-9. PubMed ID: 12373662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
    Schmidt D; Elger CE
    Epilepsy Behav; 2004 Oct; 5(5):627-35. PubMed ID: 15380112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.